Hernia Repair in Multiply Morbid Patients

PHASE4TerminatedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Ventral Hernia
Interventions
DEVICE

Strattice Reconstructive Tissue Matrix (Hernia Repair)

Hernia repair will be performed, in an open fashion and defect will be closed or reduced in size using musculofascial centralization procedures to reestablish midline.

DEVICE

Proceed Surgical Mesh (Hernia repair)

Hernia repair will be performed, in an open fashion and defect will be closed or reduced in size using musculofascial centralization procedures to reestablish midline.

Trial Locations (13)

11042

Long Island Jewish - North Shore, Lake Success

21201

University of Maryland Medical Center, Baltimore

University of Maryland, Baltimore

44106

University Hospital - Case Western, Cleveland

48503

Hurley Medical Center, Flint

55905

Mayo Clinic, Rochester

64108

Truman Medical Center, Kansas City

70112

Louisiana Status University Health Sciences Center, New Orleans

70115

Tulane University, New Orleans

University of Texas - MD Anderson Cancer Center, Houston

76508

Scott & White Medical Center, Temple

97239

Oregon Health Sciences University, Portland

02132

Boston Veterans Administration Healthcare System, West Roxbury

Sponsors

Lead Sponsor

All Listed Sponsors
lead

LifeCell

INDUSTRY

NCT00930787 - Hernia Repair in Multiply Morbid Patients | Biotech Hunter | Biotech Hunter